These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29686296)

  • 1. A novel in vitro metric predicts in vivo efficacy of inhaled silver-based antimicrobials in a murine Pseudomonas aeruginosa pneumonia model.
    Shah PN; Shah KN; Smolen JA; Tagaev JA; Torrealba J; Zhou L; Zhang S; Zhang F; Wagers PO; Panzner MJ; Youngs WJ; Wooley KL; Cannon CL
    Sci Rep; 2018 Apr; 8(1):6376. PubMed ID: 29686296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minocycline and Silver Dual-Loaded Polyphosphoester-Based Nanoparticles for Treatment of Resistant Pseudomonas aeruginosa.
    Chen Q; Shah KN; Zhang F; Salazar AJ; Shah PN; Li R; Sacchettini JC; Wooley KL; Cannon CL
    Mol Pharm; 2019 Apr; 16(4):1606-1619. PubMed ID: 30817887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and murine efficacy and toxicity studies of nebulized SCC1, a methylated caffeine-silver(I) complex, for treatment of pulmonary infections.
    Cannon CL; Hogue LA; Vajravelu RK; Capps GH; Ibricevic A; Hindi KM; Kascatan-Nebioglu A; Walter MJ; Brody SL; Youngs WJ
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3285-93. PubMed ID: 19451294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia.
    Chen C; Deslouches B; Montelaro RC; Di YP
    Clin Microbiol Infect; 2018 May; 24(5):547.e1-547.e8. PubMed ID: 28882728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of antibacterial silver nanoclusters to
    Soundy J; Day D
    J Med Microbiol; 2020 Apr; 69(4):640-652. PubMed ID: 32125966
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of inhaled nitric oxide in a rat model of Pseudomonas aeruginosa pneumonia.
    Webert KE; Vanderzwan J; Duggan M; Scott JA; McCormack DG; Lewis JF; Mehta S
    Crit Care Med; 2000 Jul; 28(7):2397-405. PubMed ID: 10921570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication of inhaled hybrid silver/ciprofloxacin nanoparticles with synergetic effect against Pseudomonas aeruginosa.
    Al-Obaidi H; Kalgudi R; Zariwala MG
    Eur J Pharm Biopharm; 2018 Jul; 128():27-35. PubMed ID: 29654885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Silver Nanoparticles on Multiple Drug-Resistant Strains of Staphylococcus aureus and Pseudomonas aeruginosa from Mastitis-Infected Goats: An Alternative Approach for Antimicrobial Therapy.
    Yuan YG; Peng QL; Gurunathan S
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.
    Shindo Y; Fuchs AG; Davis CG; Eitas T; Unsinger J; Burnham CD; Green JM; Morre M; Bochicchio GV; Hotchkiss RS
    J Leukoc Biol; 2017 Feb; 101(2):543-554. PubMed ID: 27630218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Joint Intratracheal Surfactant-Antibacterial Therapy in Experimental Pseudomonas-Induced Pneumonia.
    Birkun AA; Kubyshkin AV; Novikov NY; Krivorutchenko YL; Fedosov MI; Postnikova ON; Snitser AA
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):299-307. PubMed ID: 25517041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, and in vivo efficacy of shell cross-linked nanoparticle formulations carrying silver antimicrobials as aerosolized therapeutics.
    Shah PN; Lin LY; Smolen JA; Tagaev JA; Gunsten SP; Han DS; Heo GS; Li Y; Zhang F; Zhang S; Wright BD; Panzner MJ; Youngs WJ; Brody SL; Wooley KL; Cannon CL
    ACS Nano; 2013 Jun; 7(6):4977-87. PubMed ID: 23718195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial efficacy of silver nanoparticles against multi-drug resistant clinical isolates from post-surgical wound infections.
    Kasithevar M; Periakaruppan P; Muthupandian S; Mohan M
    Microb Pathog; 2017 Jun; 107():327-334. PubMed ID: 28411059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
    Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
    J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate independent silver nanoparticle based antibacterial coatings.
    Taheri S; Cavallaro A; Christo SN; Smith LE; Majewski P; Barton M; Hayball JD; Vasilev K
    Biomaterials; 2014 May; 35(16):4601-9. PubMed ID: 24630091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEDI3902 Correlates of Protection against Severe Pseudomonas aeruginosa Pneumonia in a Rabbit Acute Pneumonia Model.
    Le HN; Quetz JS; Tran VG; Le VTM; Aguiar-Alves F; Pinheiro MG; Cheng L; Yu L; Sellman BR; Stover CK; DiGiandomenico A; Diep BA
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483116
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term effect of erythromycin therapy on Pseudomonas aeruginosa in chronic murine model of pseudomonas pulmonary infection].
    Nagata T; Mukae H; Kadokawa T; Kaida H; Kuroki M; Yanagihara K; Asano K; Kadota J; Koji T; Kawano S
    Jpn J Antibiot; 2003 Apr; 56 Suppl A():57-9. PubMed ID: 14679749
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibacterial mechanism of silver nanoparticles in Pseudomonas aeruginosa: proteomics approach.
    Yan X; He B; Liu L; Qu G; Shi J; Hu L; Jiang G
    Metallomics; 2018 Apr; 10(4):557-564. PubMed ID: 29637212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa.
    Beringer PM; Bensman TJ; Ho H; Agnello M; Denovel N; Nguyen A; Wong-Beringer A; She R; Tran DQ; Moskowitz SM; Selsted ME
    J Antimicrob Chemother; 2016 Jan; 71(1):181-8. PubMed ID: 26433781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3,6-Di(pyridin-2-yl)-1,2,4,5-tetrazine (pytz)-capped silver nanoparticles (TzAgNPs) inhibit biofilm formation of Pseudomonas aeruginosa: a potential approach toward breaking the wall of biofilm through reactive oxygen species (ROS) generation.
    Chakraborty P; Joardar S; Ray S; Biswas P; Maiti D; Tribedi P
    Folia Microbiol (Praha); 2018 Nov; 63(6):763-772. PubMed ID: 29855854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW; Zhou QT; Cheah SE; Zhao J; Chen K; Wang J; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.